Ethical considerations on the use of monoclonals in the managed care environment.
Sbarbaro
J A
JA
University of Colorado Health Science Center, Denver, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003363:Cost Control; D003953:Diagnosis-Related Groups; D004992:Ethics, Medical; D005382:Financing, Personal; D006801:Humans; D007342:Insurance Benefits; D007400:Interprofessional Relations; D008329:Managed Care Programs / Q000191:economics; D010344:Patient Advocacy; D008486:Physician Executives; D010820:Physicians; D012106:Research; D012772:Shock, Septic / Q000628:therapy*
D000911:Antibodies, Monoclonal